BioSyent Inc. (BIOYF)
OTCMKTS · Delayed Price · Currency is USD
8.72
-0.13 (-1.47%)
Sep 2, 2025, 12:31 PM EDT
BioSyent Market Cap
BioSyent has a market cap or net worth of $97.99 million as of September 3, 2025. Its market cap has increased by 14.49% in one year.
Market Cap
97.99M
Enterprise Value
83.91M
Revenue
28.97M
Ranking
n/a
PE Ratio
16.18
Stock Price
$8.72
Market Cap Chart
Since April 24, 1997, BioSyent's market cap has increased from 9.48M to 97.99M, an increase of 933.54%. That is a compound annual growth rate of 8.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 98.89M | 11.43% |
| Dec 31, 2024 | 88.75M | 8.08% |
| Dec 29, 2023 | 82.11M | 31.23% |
| Dec 30, 2022 | 62.57M | -23.01% |
| Dec 30, 2021 | 81.27M | 2.23% |
| Dec 31, 2020 | 79.49M | 24.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 832.17M |
| Elite Pharmaceuticals | 734.61M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 655.63M |
| Northwest Biotherapeutics | 448.50M |
| CytoDyn | 376.00M |
| American Oncology Network | 343.87M |